Your browser doesn't support javascript.
loading
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
Munzone, E; Giobbie-Hurder, A; Gusterson, B A; Mallon, E; Viale, G; Thürlimann, B; Ejlertsen, B; MacGrogan, G; Bibeau, F; Lelkaitis, G; Price, K N; Gelber, R D; Coates, A S; Goldhirsch, A; Colleoni, M.
Afiliación
  • Munzone E; Division of Medical Senology, European Institute of Oncology, Milan, Italy elisabetta.munzone@ieo.it.
  • Giobbie-Hurder A; Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA.
  • Gusterson BA; Institute of Cancer Sciences, Glasgow University, Glasgow.
  • Mallon E; Southern General Hospital, Glasgow, UK.
  • Viale G; Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy.
  • Thürlimann B; Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Ejlertsen B; Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark.
  • MacGrogan G; Department of Pathology, Institut Bergonié, Bordeaux.
  • Bibeau F; Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France.
  • Lelkaitis G; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Price KN; International Breast Cancer Study Group (IBCSG) Statistical Center.
  • Gelber RD; Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA.
  • Coates AS; International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia.
  • Goldhirsch A; Program of Breast Health, European Institute of Oncology, Milan, Italy.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, Milan, Italy.
Ann Oncol ; 26(12): 2442-9, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26387144
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tamoxifeno / Triazoles / Neoplasias de la Mama / Antineoplásicos Hormonales / Nitrilos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tamoxifeno / Triazoles / Neoplasias de la Mama / Antineoplásicos Hormonales / Nitrilos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article